Lipozyt Marker
Alumni start-ups
Sector
Digital Drug
Location
Germany
Funding Start
2020
Short Description
This start-up is a first mover using mRNA-based biomarker tests for personalised diagnostics of metabolic diseases with type-2-diabetes as a first use case.
Employee Count
4
LinkedIn
https://www.linkedin.com/company/lipozyt-marker/
Management
Wolfgang Hierneis, Uwe Jensen
Company Website
http://lipozyt-marker.com/
Lipozyt finished his final fundraising campaign

Lipozyt Marker got funding through Aescuvest in 2020 already and extended the campaign until recently. On the 20th of April 2021 the Lipozyt Marker funding campaign finally ended and once more Aescuvest helped the mRna-based diagnostic start-up to reach its funding goals. 

Aescuvest enables great health innovations through equity investments. It is the leading platform to foster and fund smart healthcare ideas. This independent launch pad offers financing strategies to companies & an above-average profit share to investors.

EIT Health is one of the largest healthcare initatives wordwide. Its goal is to sustainably advance the fundamentals of healthcare and thus promote suitable future conditions for healthy living, active ageing and improved wellbeing of people across Europe.

About us

For Investors

For idea providers

Help & legal

Stay tuned

Follow us on

Subscribe to our newsletter

By clicking on ‘Sign up’, you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.